Jennifer Sue Pitrak Mcdonald

Array ( [id] => 5404618 [patent_doc_number] => 20090239932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma' [patent_app_type] => utility [patent_app_number] => 11/990655 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16579 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239932.pdf [firstpage_image] =>[orig_patent_app_number] => 11990655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220279 [patent_doc_number] => 20070161590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Methods and sequences to preferentially suppress expression of mutated huntingtin' [patent_app_type] => utility [patent_app_number] => 11/478110 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 37127 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161590.pdf [firstpage_image] =>[orig_patent_app_number] => 11478110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479538 [patent_doc_number] => 20100041738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'HYBRIDIZATION-STABILIZING CONSTRUCT' [patent_app_type] => utility [patent_app_number] => 11/993018 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8216 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041738.pdf [firstpage_image] =>[orig_patent_app_number] => 11993018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648629 [patent_doc_number] => 08802640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Oligonucleotides for RNA interference and biological applications thereof' [patent_app_type] => utility [patent_app_number] => 11/921089 [patent_app_country] => US [patent_app_date] => 2006-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5970 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 278 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11921089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398468 [patent_doc_number] => 20090318531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Small Interfering RNA Specific For HCV And Therapeutic Agent For Hepatitis C Comprising The Same' [patent_app_type] => utility [patent_app_number] => 11/915975 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6329 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318531.pdf [firstpage_image] =>[orig_patent_app_number] => 11915975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514324 [patent_doc_number] => 20090214630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Compositions and Methods for the Treatment of Inflammatory Bowel Disease Utilizing NF-KappaB Decoy Polynucleotides' [patent_app_type] => utility [patent_app_number] => 11/920214 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20727 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214630.pdf [firstpage_image] =>[orig_patent_app_number] => 11920214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672551 [patent_doc_number] => 20060177906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'IGF-I responsive gene and use thereof' [patent_app_type] => utility [patent_app_number] => 11/405121 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10493 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177906.pdf [firstpage_image] =>[orig_patent_app_number] => 11405121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514171 [patent_doc_number] => 20090214477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis' [patent_app_type] => utility [patent_app_number] => 11/911528 [patent_app_country] => US [patent_app_date] => 2006-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46239 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214477.pdf [firstpage_image] =>[orig_patent_app_number] => 11911528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5620029 [patent_doc_number] => 20060189563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease' [patent_app_type] => utility [patent_app_number] => 11/384739 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 19019 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189563.pdf [firstpage_image] =>[orig_patent_app_number] => 11384739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760905 [patent_doc_number] => 20060211850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Sequence-determined DNA fragments encoding RNA polymerase proteins' [patent_app_type] => utility [patent_app_number] => 11/370216 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18216 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211850.pdf [firstpage_image] =>[orig_patent_app_number] => 11370216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656500 [patent_doc_number] => 20060142236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Antisense oligonucleotide modulation of raf gene expression' [patent_app_type] => utility [patent_app_number] => 11/364481 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16613 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142236.pdf [firstpage_image] =>[orig_patent_app_number] => 11364481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391625 [patent_doc_number] => 20090208938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Use of the MCM8 Gene for the Preparation of a Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 11/884053 [patent_app_country] => US [patent_app_date] => 2006-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18729 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208938.pdf [firstpage_image] =>[orig_patent_app_number] => 11884053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5614416 [patent_doc_number] => 20060116344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Remedy and preventive for diseases caused by NF-kB' [patent_app_type] => utility [patent_app_number] => 11/324230 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3177 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116344.pdf [firstpage_image] =>[orig_patent_app_number] => 11324230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5679671 [patent_doc_number] => 20060185027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Systems and methods for identifying miRNA targets and for altering miRNA and target expression' [patent_app_type] => utility [patent_app_number] => 11/317660 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 58531 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20060185027.pdf [firstpage_image] =>[orig_patent_app_number] => 11317660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776738 [patent_doc_number] => 20060105378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Tenascin-C nucleic acid ligands' [patent_app_type] => utility [patent_app_number] => 11/300662 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11947 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105378.pdf [firstpage_image] =>[orig_patent_app_number] => 11300662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4970720 [patent_doc_number] => 20070110722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Methods and compositions for the Synthesis of RNA and DNA' [patent_app_type] => utility [patent_app_number] => 11/164963 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20070110722.pdf [firstpage_image] =>[orig_patent_app_number] => 11164963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5682921 [patent_doc_number] => 20060199191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Methods and compositions for the synthesis of RNA and DNA' [patent_app_type] => utility [patent_app_number] => 11/164961 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3860 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199191.pdf [firstpage_image] =>[orig_patent_app_number] => 11164961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776737 [patent_doc_number] => 20060105377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Screening to optimize RNAi' [patent_app_type] => utility [patent_app_number] => 11/297068 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10003 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105377.pdf [firstpage_image] =>[orig_patent_app_number] => 11297068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582250 [patent_doc_number] => 08772254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Method and constructs for delivering double stranded RNA to pest organisms' [patent_app_type] => utility [patent_app_number] => 11/666017 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 91 [patent_no_of_words] => 36696 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11666017 [rel_patent_id] =>[rel_patent_doc_number] =>)